Protein BLST Helps Protect Spinal Discs From Aging

University of Utah researchers found that restoring the BLST protein reduced cellular aging and DNA damage in human disc cells.

Updated on Nov. 19, 2026 in Science

Protein BLST Helps Protect Spinal Discs From Aging

Live Poll

Do you trust scientists to deliver effective new back pain treatments?

University of Utah researchers characterized a protein called BLST, also known as ZNF865, that may help protect spinal discs from age-related damage. Levels of the protein were lower in older and damaged discs, and restoring it in human disc cells using CRISPR reduced signs of cellular aging and DNA damage.

Why it matters

Back pain ranks as the third leading cause of disability as measured by disability-adjusted life years, so a better understanding of disc degeneration could inform future treatments. The study is the first functional characterization of the BLST gene and protein, opening a new line of inquiry into spinal health.

The study used CRISPR to alter BLST levels in human cells and in mouse and rat models, with reduced BLST activity in rodents producing disc degeneration and pain-related behaviors. Whether these results translate to people remains unknown, as additional preclinical studies and clinical trials are still needed.

The players

University of Utah

A public research university in Salt Lake City that conducted the study through its biomedical engineering researchers.

Huntsman Cancer Institute

A cancer research institution affiliated with the University of Utah that collaborated on the study.

The details

Led by Robby D. Bowles, an associate professor of biomedical engineering, the team used the gene-editing tool CRISPR to increase or decrease BLST levels and measured the effects on spinal disc health. The findings were published in Aging Cell and are the first functional characterization of the BLST gene and protein.

Timeline

  1. November 18, 2026: University of Utah study on BLST protein publicized

Big Picture

The study applies the CRISPR gene-editing tool to a previously uncharacterized gene, extending its use beyond established targets into spinal disc biology. The researchers suggest the mechanisms identified may also apply to cancer, neurodegeneration, and other diseases involving DNA damage.

For readers living with back pain, the research points toward a potential future biological target, though no treatment is available yet. Any therapy based on BLST would still require preclinical validation and clinical trials before it could reach patients.

The takeaway

Back pain is a major source of disability, and early laboratory work like this shows that the biology of spinal disc aging may be more modifiable than previously assumed. Continued research will determine whether that potential can be turned into safe treatments.

Further reading

Explore more Life Sciences coverage to see how research like this fits into broader biomedical progress in Utah.

Source note: This article includes information reported by News-Medical.

Live Poll

Do you trust scientists to deliver effective new back pain treatments?